Home World News EMA Recommends Extending Indications for Decitabine / Cedazuridine World News EMA Recommends Extending Indications for Decitabine / Cedazuridine By Ogkologos - May 29, 2026 267 0 Facebook Twitter Google+ Pinterest WhatsApp New indication concerns a combination with venetoclax for the treatment of adult patients with newly diagnosed AML Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Childhood cancer survivors at greater risk of ill health November 22, 2021 One Year in Cancer Research and Much to Celebrate December 20, 2024 Encouraging Single-Agent Antitumour Activity of Divarasib Across KRAS G12C-positive Tumours September 5, 2023 ESMO Congress 2022, 9-13 September August 22, 2022 Load more HOT NEWS Meet Rosalie: St. Jude Children’s Research Hospital’s New Service Dog For... Cancer Research UK report highlights stark cancer inequalities across Scotland Breast Cancer Patient Who Continued Teaching Throughout Her Treatment Wins Teacher... Qué debe saber sobre las pruebas de ADN en el hogar...
